














| SCIENTIFIC ADVISORY BOARD
Prof. Ruben A. Abagyan, Ph.D., Department of Molecular Biology, The Scripps Research Institute; Genomics Institute of the Novartis Research Foundation, La Jolla, CA
Prof. Henrik G. Bohr, Ph.D., Technical University of
Denmark, Lyngby, Denmark
Prof. Jakob Bohr, Ph.D., Technical University of Denmark,
Lyngby, Denmark
Prof. Søren Brunak, Ph.D., Technical University of Denmark,
Lyngby, Denmark
Dr. Stephen Bryant, Ph.D., National Institutes of Health,
Washington, DC
Prof. David A. Case, Ph.D., The Scripps Research Institute,
La Jolla, CA
Prof. Edgar Engleman, M.D., Stanford University School
of Medicine, Stanford, CA
Prof. Tim Gallagher, Ph.D., University of Bristol,
Bristol, UK
Prof. Minoru Kanehisa, Ph.D., Kyoto University,
Kyoto, Japan
Dr. Bernard Kasten, Jr., M.D., FCAP,
Quest Diagnostics Incorporated Ventures, Teterboro, NJ
Prof. Michael Levitt, Ph.D., Stanford University School
of Medicine, Stanford, CA
Prof. Arthur J. Olson, Ph.D., The Scripps Research Institute,
La Jolla, CA
Dr. John Reed, M.D., Ph.D., Burnham Cancer Research
Institute,
La Jolla, CA
Prof. Douglas W. Smith, Ph.D., Univ. of California, San
Diego, CA
OTHER MANAGEMENT ADVISORS
Dr. Juerg Geigy, Basel, Switzerland
Mr. Theodor Heinrichs, San Francisco, CA
Mr. Michael J. Savage, San Diego, CA
|
|